Archives
-
EVMPs Expand Extrahepatic mRNA Delivery
2026-09-11
The reference study introduces a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) designed to overcome the hepatic bias of many existing mRNA delivery systems. By combining an engineered virus-mimicking peptide with selected phospholipids, the authors achieved lung- and spleen-directed delivery and demonstrated therapeutic activity with IL-12 mRNA in a metastatic lung tumor model.
-
RIPA Lysis Buffer (Strong) for Glioma Signaling
2026-09-11
RIPA Lysis Buffer (Strong) can support a rigorous glioma protein workflow when biochemical extraction is aligned with chromatin and signaling assays. This article explains how to use a strong Radioimmunoprecipitation assay buffer to interrogate the CSRP2–PDGFRA–PI3K/AKT axis without confusing protein-level validation with locus-level mechanism.
-
KPT-330 (Selinexor) Workflow Guide
2026-09-10
Build reproducible nuclear-export inhibition assays with KPT-330 (Selinexor), from DMSO stock preparation through apoptosis, cell-cycle, combination, and xenograft readouts. This guide translates basal-like TNBC findings into practical cancer research workflows while highlighting controls, dose selection, and troubleshooting strategies.
-
Pomalidomide (CC-4047) in Myeloma Workflows
2026-09-10
Build genotype-aware multiple myeloma assays around Pomalidomide (CC-4047), linking cytokine modulation to cell-state and viability measurements. This practical guide covers dosing, erythroid progenitor cell differentiation studies, model selection, and troubleshooting for reproducible hematological malignancy research.
-
Dynasore: From Endocytosis Blocker to Causal Tool
2026-09-09
Dynasore is a dynamin GTPase inhibitor that helps researchers convert vesicle-traffic observations into testable causal models. This article connects its mechanism to viral-entry evidence and provides an assay framework for endocytosis research, neuronal studies, and signal-transduction analysis.
-
SB 431542: Precision ALK5 Inhibition Workflows
2026-09-09
SB 431542 provides a practical way to perturb TGF-β signaling while preserving a focused receptor profile for primary trophoblast, immune-cell, and cancer assays. This guide connects high-purity HLA-G+ extravillous trophoblast workflows with phospho-Smad2 measurements, co-culture design, glioma proliferation studies, and troubleshooting strategies.
-
SARS-CoV-2 N Protein Redirects GADD34 Immunity
2026-09-08
Liu et al. identify an atypical stress-granule mechanism in which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA into N+/G3BP1+ foci, weakening IRF3 nuclear localization and interferon production. The study connects viral condensate biology with innate-immune suppression and provides a mechanistic framework for evaluating antiviral signaling perturbations without implying that receptor-directed compounds have established antiviral activity.
-
Ampicillin sodium: Workflows for Antibacterial Assays
2026-09-08
Ampicillin sodium supports reproducible β-lactam susceptibility testing, resistance profiling, and bacterial selection workflows when concentration, inoculum, and storage are controlled. This guide translates transpeptidase inhibition and comparative β-lactam research into practical assay design and troubleshooting decisions.
-
Guanabenz Acetate in Stress-Granule Assays
2026-09-07
Guanabenz Acetate is an α2-adrenergic receptor agonist for dissecting receptor-proximal signaling alongside stress-granule and innate-immunity readouts. This article presents a hypothesis-driven assay framework grounded in recent SARS-CoV-2 nucleocapsid research while clearly separating established evidence from exploratory applications.
-
Targeted mRNA Nanoparticles After Ischemic Stroke
2026-09-07
Gao and colleagues developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to modulate microglia in ischemic brain lesions. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and mitigated neurological deficits, while suggesting a therapeutic window extending to 72 hours after stroke.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-09-05
A bioRxiv study identifies the host protein CLCC1 as an essential factor for the membrane-fusion step of herpes simplex virus 1 nuclear egress. Its CRISPR-based approach connects failed capsid release with perinuclear vesicle accumulation and reveals a related role for CLCC1 in nuclear pore complex insertion, providing a mechanistic framework for studying herpesvirus–host membrane biology.
-
Bafilomycin C1 in High-Content Autophagy Screens
2026-09-04
Use Bafilomycin C1 as a controlled V-ATPase perturbation to connect lysosomal acidification, autophagic flux, and high-content cellular phenotypes. This workflow emphasizes dose-matrix design, orthogonal validation, and careful separation of acidification effects from general cytotoxicity.
-
RNA G-Quadruplexes Shape TDP-43 Toxicity
2026-09-04
Oldani et al. show that RNA G-quadruplexes directly influence TDP-43 aggregation, condensation, cellular distribution, and toxicity across biochemical and cellular models. The work positions G-quadruplex structure as a potential regulatory variable in ALS-related protein misfolding, while also highlighting the need to distinguish RNA-structure mechanisms from DNA-targeted applications.
-
iPSC Airway Models for Cystic Fibrosis Drug Testing
2026-09-03
The reference study develops a multimodal induced pluripotent stem cell platform that generates airway epithelial models from individuals with common or rare CFTR variants. By combining forskolin-induced swelling in three-dimensional spheroids with functional testing in polarized mucociliary cultures, the platform detects genotype-specific baseline activity and modulator responses, supporting more individualized preclinical drug evaluation.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-09-03
A 2024 iScience study combined quantitative serum proteomics with Mfuzz clustering and WGCNA to identify proteins associated with diabetic nephropathy progression. HMGB1 was prioritized as a candidate early-monitoring biomarker because its serum pattern tracked renal-function changes and was reproduced under high-glucose conditions in cellular and animal models.